PHILADELPHIA PHARMACEEUTICALS

ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ

PM 04:21:34 2022-04-27 :ﺦﻳﺭﺎﺘﻟﺍ

ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺞﺋﺎﺘﻧ :ﻉﻮﺿﻮﻤﻟﺍ

To: Jordan Securities Commission,

Amman Stock Exchange

Company's Name: PHILADELPHIA PHARMACEEUTICALS Date: 27-04-2022 04:21:34 PM

Subject: The Resolutions Of The General Assembly Meeting

ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ 04:00 ﻰﻠﻋ 2022-04-27 ﺔﻋﺎﺴﻟﺍ َﺪﻘُﻋ ﻝﻼﺧ ﻦﻣ ﻲﻓ ﻚﻟﺫﻭ.ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ ﺔﻛﺮﺸﻟ ﺔﻳﺩﺎﻌﻟﺍ ﺭﻮﻀﺣ ﺔﺒﺴﻨﺑﻭ ﻡﻭﻭﺯ ﺮﺒﻋ ﻲﻧﻭﺮﺘﻜﻟﻻﺍﻭ ﻲﺋﺮﻤﻟﺍ ﻝﺎﺼﺗﻻﺍ ﺔﻴﻨﻘﺗ

%90.9

-:ﺔﻴﻟﺎﺘﻟﺍ ﺕﺍﺭﺍﺮﻘﻟﺍ ﺫﺎﺨﺗﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﻼﺧ ﻢﺗ

The Ordinary General Assembly Meeting of PHILADELPHIA PHARMACEEUTICALS was held on 04:00 On 27-04-2022 at Zoom meeting, the shareholders participation in the Assembly Meeting was 90.9% The following decisions were adopted at the Meeting:-

ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ ﻖﺑﺎﺴﻟﺍ

Subject: Approving the minutes of the previous year Ordinary General Assembly Meeting

ﻖﺑﺎﺴﻟﺍ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ 2021-05-18 ﺦﻳﺭﺎﺘﺑ ﺪﻘﻌﻨﻤﻟﺍﻭ

Approving the minutes of the previous year Ordinary General Assembly Meeting which was held on 18-05-2021

ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ

Subject: Approving The Report of the Board of Directors on the activities of the Company, for the year ended on specified date

ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ 2021-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ

Approving The Report of the Board of Directors on the activities of the Company, for the year ended on 31-12-2021

ﻦﻋ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ

Subject: Approving the Report of the Company's auditors on its financial statements

ﺕﺎﻧﺎﻴﺒﻟﺍ ﻦﻋ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ 2021-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ

Approving the Report of the Company's auditors on its financial statements, for the year ended on 31-12-2021

ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ

Subject: Approving the Financial Statements for the year ended on

-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ

2021-12

Approving the Financial Statements for the year ended on 31-12-2021

ﻊﻓﺪﻟﺎﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺡﺍﺮﺘﻗﺍ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ

Subject: Approving of the Board of Director's proposal to pay

ﻰﻠﻋ ﺡﺎﺑﺭﺃ ﻊﻳﺯﻮﺗ ﻥﺎﺸﺑ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺡﺮﺘﻘﻣ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ

Approving of the Board of Director's proposal to pay 6%

PHILADELPHIA PHARMACEEUTICALS

as cash dividends to the shareholders and distributing 0% as bonus shares

ﻝﺎﻤﻟﺍ ﺱﺍﺭ ﻦﻣ 6% ﺔﻴﺴﻨﺑ ﺔﻳﺪﻘﻧ ﺡﺎﺑﺭﺍ ﻦﻋ ﺓﺭﺎﺒﻋ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ ﻝﺎﻤﻟﺍ ﺱﺍﺭ ﻦﻣ 0% ﺔﻴﺴﻨﺑ ﺔﻴﻧﺎﺠﻣ ﻢﻬﺳﺍ ﻊﻳﺯﻮﺗﻭ

Subject: Discharging the board's members from their liabilities in respect of the financial year ended

ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ :ﻉﻮﺿﻮﻤﻟﺍ ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ ﻢﻬﺗﺎﻓﺮﺼﺗ

Discharging the board's members from their liabilities in respect of the financial year ended 31-12-2021

ﻢﻬﺗﺎﻓﺮﺼﺗ ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ 2021-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ

Subject: Approving the appointment / reappointment of the auditors for the financial year and authorizing the board of directors to determine their fees

ﺕﺎﺑﺎﺴﺤﻟﺍ ﻲﻘﻗﺪﻣ ﻦﻴﻴﻌﺗ ﺓﺩﺎﻋﺇ / ﻦﻴﻴﻌﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ ﻢﻬﺑﺎﻌﺗﺃ ﺪﻳﺪﺤﺘﻟ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗﻭ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ

Approving the appointment/reappointment of the auditors International Professional Bureau for the financial year 31-12-2022.And authorizing the board of directors to determine their fees

ﺓﺩﺎﺴﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﻦﻴﻴﻌﺗ ﺓﺩﺎﻋﺍ ﻭﺍ/ ﻦﻴﻴﻌﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ

ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻖﻴﻗﺪﺘﻟ International Professional Bureau

ﺪﻳﺪﺤﺘﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗ ﻭ 2022-12-31 ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﻢﻬﺑﺎﻌﺗﺍ

Subject: Any other matters which the General Assembly proposes to include in the agenda

ﻲﻓ ﺎﻬﺟﺍﺭﺩﻹ ﺔﻣﺎﻌﻟﺍ ﺔﻴﻌﻤﺠﻟﺍ ﺎﻬﺣﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ :ﻉﻮﺿﻮﻤﻟﺍ ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ

Any other matter which the General Assembly proposes to include in the agenda, and are within the work scope of the General Assembly in its ordinary meetings, provided that such a proposal is approved by shareholders representing not less than 10% of the shares represented in the meeting

ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺎﻬﺟﺍﺭﺩﺇ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺡﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ ﻥﺃ ﻰﻠﻋ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﻱﺩﺎﻌﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﺎﻤﻋﺃ ﻕﺎﻄﻧ ﻲﻓ ﻞﺧﺪﻳﻭ ﻦﻣ ﺩﺪﻋ ﺔﻘﻓﺍﻮﻤﺑ ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺡﺍﺮﺘﻗﻻﺍ ﺍﺬﻫ ﺝﺍﺭﺩﺃ ﻥﺮﺘﻘﻳ ﻲﻓ ﺔﻠﺜﻤﻤﻟﺍ ﻢﻬﺳﻷﺍ ﻦﻣ (%10) ﻦﻋ ﻞﻘﻳ ﻻ ﺎﻣ ﻥﻮﻠﺜﻤﻳ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ

ﻯﺮﺧﺃ ﺭﻮﻣﺍ ﺔﻳﺃ ﺪﺟﻮﻳ ﻻ

ﻯﺮﺧﺃ ﺭﻮﻣﺍ ﺔﻳﺃ ﺪﺟﻮﻳ ﻻ

Please accept our sincere thanks and appreciation. Chairman of Board of Directors

User Name: Belal Salameh

.ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ

Belal Salameh :ﻡﺪﺨﺘﺴﻤﻟﺍ ﻢﺳﺍ

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Philadelphia Pharmaceuticals Industry Co. PSC published this content on 27 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2022 22:20:13 UTC.